Blair McNeill

Sr Vice President and Head of Cell Therapy @Sumitomo Pharma America, Inc.

Raleigh, NC, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2023 — Present

Sr Vice President and Head of Cell Therapy @Sumitomo Pharma America, Inc.

View department →

Morrisville, NC, US

EDUCATION

1990 — 1992

California State University, Northridge

MS, Protein Chemistry

1998 — 2001

VANDERBILT UNIVERSITY MEDICAL CENTER

Doctor of Philosophy (Ph.D.), Molecular Physiology and Biophysics

1992 — 1998

Vanderbilt University

PhD, Molecular Physiology and Biophysics

1984 — 1988

University of California, Davis

BS, Bacteriology

SKILLS

ChromatographyCell BiologyBiotechnologyProtein PurificationElisaGlpPharmacologyFiltrationAseptic TechniqueIn VitroToxicologyBioreactorSopFdaProcess SimulationLife SciencesTechnology TransferClinical DevelopmentGeneticsProteomicsLifesciencesProtein ExpressionTransfectionSignal TransductionBiochemistryAssay DevelopmentLimsSds-PageImmunoassaysFormulationLaboratoryBiopharmaceuticalsGmpAnalytical ChemistryCellDrug DiscoveryHplcTissue CultureDnaInd

ABOUT BLAIR MCNEILL

A protein scientist by training and an expert in Biologics CMC; leads pharmaceutical development, process development and clinical/commercial manufacturing of Drug Substance and Drug Product for numerous companies’ product pipeline. Continues to align global business and technical strategies within organization and across parent organization. Extensive expertise in strategic and technical strategies throughout drug development lifecycle for biologics and gene therapies, including cell line development process development, analytical development and manufacturing. Has worked extensively with startup organizations, with the last two selling assets for $900 million and $3 billion. Additionally has strong business acumen working with businesses development for asset acquisition diligence and current business unit expansion. Leads collaborations of cross functional teams both internally and externally, and with partner CDMOs and CROs to optimize strategies and processes to meet corporate goals and regulatory expectations, both in the United States and Europe.A strong leader of people, teams, and drug development programs, a SME in Biologics and Gene Therapy development and manufacturing across product life cycle, he excels at turning theories and ideas into actions and products in a practical and compliant manner while building an engage and motivated team of professionals.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Blair McNeill — Sr Vice President and Head of Cell Therapy at Sumitomo Pharma America, Inc. in Raleigh, NC, US | Unifers